Eyenovia, Inc. and SGN Nanopharma Inc. are?collaborating to develop and validate a novel drug-device combination?featuring the companies’ Optejet dispenser and proprietary platform-based cyclosporine formulation to treat chronic dry eye disease DED). Learn more on Glance: https://lnkd.in/gHf2DaxY #GlanceNews #eyecare Storm Charbonneau
SGN Nanopharma Inc
制药业
Tampa，Florida 461 位关注者
A Cutting-Edge, Clinical-Stage, Revenue-Generating Nanotherapeutics Company
关于我们
Creating Impactful, Clinically Differentiated Medicines
- 网站
-
https://sgnnanopharma.com/
SGN Nanopharma Inc的外部链接
- 所属行业
- 制药业
- 规模
- 11-50 人
- 总部
- Tampa，Florida
- 类型
- 私人持股
- 创立
- 2010
地点
-
主要
获取路线
3720 Spectrum Blvd
Suite 125
US，Florida，Tampa，33612
SGN Nanopharma Inc员工
-
Vineet Singhal
Global Pharmaceutical Business Leader
-
Pranav Patel
Formulations I Synthesis I Scale-up I Tech Transfer I 505(b)2 I DMF I ANDA I QC I IND-NDA I Pre-clinical I Neuro I Validations I Onco I Sterile I…
-
Carlos Sampaio
Global Commercial Executive | Strategy & Consumer Focus | Marketing & Sales | Restructuring | Talent Mentor | FMCG | OTC
-
Dev Patel
MS Biotechnology Graduate | Research Scientist at SGN NanoPharma
动态
-
Excited to be collaborating with Eyenovia to advance innovative dry eye solutions, including our SGN-101 formulation, leveraging the Optejet? technology for enhanced patient convenience and care. #DryEye #Innovation #SGNNanopharma
EYEN-510 (Dry Eye) -- Formulation with SGN-101 and the Optejet?
https://eyenovia.com